By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Acasti Pharma 

225 Promenade du Centropolis
Suite 200
Laval  Quebec  H7T 3B3  Canada
Phone: 450-687-2262 Fax: 450-687-2272




Company News
Acasti Pharma Receives Extension to Regain Compliance With NASDAQ Minimum Bid Price Rule 5/11/2015 10:25:34 AM
Acasti Pharma Announces Departure Of Chief Financial Officer 4/30/2015 7:37:42 AM
Acasti Pharma Granted Composition & Use Patent In China 3/25/2015 7:29:58 AM
Acasti Pharma Receives Full Data For Phase II TRIFECTA Trial 3/2/2015 7:09:20 AM
Acasti Pharma Announces Third Quarter Results 1/14/2015 7:24:34 AM
Acasti Pharma Receives NASDAQ Notification Regarding Minimum Bid Requirements 11/11/2014 8:49:24 AM
Acasti Pharma Announces Grant Of Stock Options 10/20/2014 6:15:57 AM
Acasti Pharma Announces Second Quarter Results 10/14/2014 1:40:28 PM
Acasti Pharma Announces Positive Top-Line Pharmacokinetic Results 9/30/2014 7:04:00 AM
Acasti Pharmai Reports Successful Capre® Phase 2 TRIFECTA Results Proving Statistically Significant Improvements In Triglycerides & Non-HDL-C 9/29/2014 9:02:43 AM